DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications

DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications

Abstract Background DNA damage repair (DDR) pathways modulate cancer risk, progression, and therapeutic responses. Nonetheless, the characteristics and significance of DDR alterations in clear cell renal cell carcinoma (ccRCC) remain undefined. This study aimed to explore the predictive role, molecu...

Full description

Bibliographic Details
Main Authors:	Xiao Jing, Xiangcheng Qin, Hao Liu, Huanhuan Liu, Huina Wang, Jiayue Qin, Yanui Zhang, Shanbo Cao, Xiaodong Fan
Format:	Article
Language:	English
Published:	BMC 2024-02-01
Series:	European Journal of Medical Research
Subjects:	Clear cell renal cell carcinoma (ccRCC) DNA damage repair (DDR) Prognosis Tumor microenvironment Tumor mutational burden (TMB)
Online Access:	https://doi.org/10.1186/s40001-024-01678-x

Similar Items

Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma
by: Songchen Han, et al.
Published: (2022-06-01)

Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma
by: Fahui Liu, et al.
Published: (2022-06-01)

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
by: Cesar U. Monjaras-Avila, et al.
Published: (2023-04-01)

Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
by: Zhulin Wu, et al.
Published: (2020-11-01)

Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
by: Dian Xia, et al.
Published: (2023-03-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
by: Zhixun Bai, et al.
Published: (2022-12-01)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
by: Jin Zhang, et al.
Published: (2020-12-01)

SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma
by: Lingyu Guo, et al.
Published: (2023-03-01)

Clear cell renal cell carcinoma: immunological significance of alternative splicing signatures
by: Jiayu Zhang, et al.
Published: (2024-01-01)

Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma
by: Rui Zeng, et al.
Published: (2022-09-01)

Metabolic reprogramming of clear cell renal cell carcinoma
by: Haiyan Zhu, et al.
Published: (2023-06-01)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
by: Qi Wang, et al.
Published: (2022-05-01)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
by: Guangjian Zhao, et al.
Published: (2022-12-01)

STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma
by: Jiyue Wu, et al.
Published: (2022-11-01)

Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy
by: Enyu Lin, et al.
Published: (2022-05-01)

Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
by: Gang Tang, et al.
Published: (2022-05-01)

The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
by: Alessandra Cinque, et al.
Published: (2022-10-01)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
by: Bao Wang, et al.
Published: (2022-10-01)

Targeting the Deterministic Evolutionary Trajectories of Clear Cell Renal Cell Carcinoma
by: Adam Kowalewski, et al.
Published: (2020-11-01)

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
by: Jun Luo, et al.
Published: (2020-06-01)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
by: Kai Gan, et al.
Published: (2022-10-01)

Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy
by: Cuijian Zhang, et al.
Published: (2022-11-01)

A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma
by: Lei Zhang, et al.
Published: (2023-08-01)

Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma
by: Qiming Gong, et al.
Published: (2023-07-01)

The epigenetic landscape of clear-cell renal cell carcinoma
by: Katarzyna Kluzek, et al.
Published: (2015-05-01)

Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
by: Hongzhi Wang, et al.
Published: (2021-11-01)

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
by: Kun Chang, et al.
Published: (2022-12-01)

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma
by: Takafumi Narisawa, et al.
Published: (2023-02-01)

Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis
by: Youwei Yue, et al.
Published: (2023-10-01)

The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features
by: Bo Geng, et al.
Published: (2023-12-01)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
by: Fan Zhang, et al.
Published: (2022-09-01)

Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype
by: Mark Farha, et al.
Published: (2023-11-01)

TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients’ survival
by: Xiao W, et al.
Published: (2018-11-01)

M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT
by: Yingwei Xie, et al.
Published: (2021-12-01)

5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma
by: Can Chen, et al.
Published: (2022-12-01)

Identifying molecular subtypes and tumor microenvironment infiltration signatures in kidney renal clear cell carcinoma based on stemness-associated disulfidptosis genes by integrating machine learning, single-cell analyses and experimental validation
by: Hongquan Liu, et al.
Published: (2024-02-01)

Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma
by: Corina Daniela Ene, et al.
Published: (2023-12-01)

Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy
by: Xuan Zhou, et al.
Published: (2022-07-01)

CD146 as a Prognostic-Related Biomarker in ccRCC Correlating With Immune Infiltrates
by: Zheng Lv, et al.
Published: (2021-12-01)

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma
by: Xu Sun, et al.
Published: (2023-10-01)